Search

Scholarly Works (1 results)

Article
Peer Reviewed

Dexpramipexole is ineffective in two models of ALS related neurodegeneration

Finkbeiner, Steven;
Vieira, FG;
LaDow, E;
Moreno, A;
Kidd, JD;
Levine, B;
Thompson, K;
Gill, A;
Perrin, S

UC San Francisco Previously Published Works (2014)

© 2014 Vieira et al.Treatment options for people living with amyotrophic lateral sclerosis (ALS) are limited and ineffective. Recently, dexpramipexole (RPPX) was advanced into human ALS clinical trials. In the current studies, we investigated RPPX in two p